2:19 am Pfizer’s novel CDK 4/6 inhibitor palbociclib plus Letrozole significantly prolonged progression-free survival in patients with advanced breast cancer

more

View todays social media effects on PFE

View the latest stocks trending across Twitter. Click to view dashboard

See who Pfizer is hiring next, click here to view